tert-Butyl (cis-4-(3-hydroxypropyl)cyclohexyl)carbamate

Catalog No.: 
ACRADD621
CAS No.: 
1212377-95-1
Molecular Formula: 
C14H27NO3
Molecular Weight: 
257.37
tert-Butyl (cis-4-(3-hydroxypropyl)cyclohexyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$261.00InquiryInquiry
250mg97%$505.00InquiryInquiry
1g97%$2000.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (cis-4-(3-hydroxypropyl)cyclohexyl)carbamate
IUPAC Nametert-butyl ((1s,4s)-4-(3-hydroxypropyl)cyclohexyl)carbamate
MDL No.MFCD03844622
Molecular FormulaC14H27NO3
Molecular Weight257.37
SMILESCC(C)(C)OC(=O)N[C@H]1CC[C@@H](CCCO)CC1
InChI KeyVUUKLWPNFXOFGM-TXEJJXNPSA-N
SynonymTERT-BUTYL CIS-4-(3-HYDROXYPROPYL)CYCLOHEXYLCARBAMATE;tert-butyl N-[4-(3-hydroxypropyl)cyclohexyl]carbamate;Carbamic acid, N-[cis-4-(3-hydroxypropyl)cyclohexyl]-, 1,1-dimethylethyl ester
CAS No.1212377-95-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACRADD621 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRADD621 route product structure diagram
    ACRADD6211212377-95-1
Inquiry

2. ACRADD621 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRADD621 route product structure diagram
    ACRADD6211212377-95-1
Inquiry

3. ACRADD621 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRADD621 route product structure diagram
    ACRADD6211212377-95-1
Inquiry

Comments (0)